FDA Drug Application (202088) for SUPRENZA by CITIUS PHARMS

Back to FDA Applications sponsored by CITIUS PHARMS

Application Number202088
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage15MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUPRENZA
Active IngredientPHENTERMINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PHENTERMINE HYDROCHLORIDE11


Back to FDA Applications sponsored by CITIUS PHARMS